Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sinobiomed, a developer of genetically engineered recombinant protein drugs and vaccines, has appointed Lionel Choong as its new CFO. In addition, Mr Choong has been appointed to the company's audit committee.
Subscribe to our email newsletter
As CFO, Mr Choong will oversee the company’s various financial functions, including finance and accounting, financial planning and analysis, regulatory and risk management, and facilities development.
Mr Choong will also be involved with other corporate activities working with the company’s CEO, Banyun Yang, to develop strategies and tactics for long-term growth.